Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
72 TaiJ.LiuW.LiY.LiL.HlscherC
Serum BDNF levels are consistently lower in patients with major depressive disorder compared to healthy controls, and successful antidepressant treatment normalizes these levels
Thus far, the study has shown results indicating a pharmacokinetic profile supportive of once-daily dosing, with a safety profile consistent with previous danuglipron investigations, including no observed liver enzyme elevations among over 1,400 participants Danuglipron (PF-06882961) is an experimental medication administered orally as a tablet and is currently not approved by regulatory authorities
Skeptics counter that those figures come from voluntary reporting rather than controlled trials, and that questions remain about immunogenicity, whether the body mounts an immune response to the peptide
Dial the dose selector to the flow check symbol
